Menu
Synergy in Action

2017 Autumn Conference includes Joint Day with ECNP

31 August – 02 September, 2017   //   Le Meridien Etoile, Paris, FR

Distinguished Poster Award Recipients:

Effect of High within Subject Variance at Research Sites on Placebo Response and Drug Placebo Separation in Acute Schizophrenia Trials – A Post Hoc Analysis (Kott)

Replication of a Statistical Method to Reduce Pseudospecificity and Enhance Understanding of Score Changes Among PANSS Factors (Mahableshwarkar)

All Poster PDFs and Abstracts are available at the end of the second day.

31 August 2017

Welcome Reception

1 September 2017
(Includes Joint Sessions with ECNP)

Welcome from the Presidents S Marder
slides 
slides
C Arango
slides 
slides
 video
Beyond Efficacy: Hard Outcomes in Treatment Studies Chairs:
N Schooler
G Goodwin
  Introduction G Goodwin
slides 
slides
 video
  Within-subject comparison as a tool to explore effectiveness in register studies M Landén
slides 
slides
 video
  Relapse prevention studies: What happens after drop out? S Leucht
slides 
slides
 video
  Industry Perspective: Risk characterization utilizing external data sources: A methodological consideration for clinical trials with high subject drop-out J Geier
slides 
slides
 video
  Regulatory Comment/Panel Audience Discussion M Tome
 
video
Speakers
 
video
Clinician Reported Outcomes in Multinational CNS Trials: Practical Guidance on Translation and Cultural Adaptation Chairs:
A Kalali
E Vieta
  Introduction and background A Kalali
 
video
  The impact of language and culture on implementing multinational clinical trials M Vance
slides 
slides
 video
  Cultural learnings implementing multinational clinical trials E Vieta
slides 
slides
 video
  Guidance document – overview and highlights  E Pappadopulos
slides 
slides
 video
  Panel and audience discussion Speakers
 
video
Drug Development for Negative Symptoms in Schizophrenia: What Have We Learned?  What Can We Do Better? Chairs:
D Umbricht
C Arango 
  Welcome and introduction D Umbricht
 
video
  Negative symptoms: Prevalence, specificity, course and other characteristics M Weiser
slides 
slides
 video
  Preclinical models of negative symptoms and their implications for clinical trials M Kas
slides 
slides
 video
  Negative symptoms: Clinical assessments, biomarkers and the role of reward processing J Gold
slides 
slides
 video
  Lessons learned in recent trials in negative symptoms D Umbricht
slides 
slides
 video
  Conclusion and next steps J Lieberman
slides 
slides
 video
  Panel discussion/Regulatory Comment Moderator:
J Lieberman
 
video
  Concluding remarks C Arango
  Joint meeting adjournment S Marder
C Arango
 
video
ISCTM Poster Session Poster PDFs and Abstracts

2 September 2017

 
Behavioral and Psychiatric Symptoms in Dementia (BPSD): A Way Forward? Chairs:
L Ereshefsky
L Pani
  Background, brief overview and session’s purpose L Ereshefsky
L Pani
  Segment 1- Agitation in Alzheimer’s Disease  
  Lessons Learned – Part One – Agitation in Alzheimer’s Disease – Progress in Trials Designs B Creese
slides 
slides
 video
  Lessons Learned – Part Two – Agitation in Alzheimer’s Disease – Developing New Treatments P Rosenberg
slides 
slides 
 video
  Comments from Industry Perspective S Dube
slides 
slides
 video
  Regulatory Viewpoints – Agitation in AD  V Mantua
slides 
slides
 video
T Farchione
slides 
slides
 video
  Panel – Audience discussion – Agitation in AD Facilitators:
J Rasmussen
J Bell
Agitation Panel
 
video
  Segment 2 – Apathy in Alzheimer’s Disease  
  Why focus on apathy? Diagnosis, symptoms assessment, methodology framework D Miller
slides 
slides
 video
  Neuro-circuitry and implications for drug development: ADMET trials, and study designs for treatment of apathy K Lanctot
slides 
slides
 video
  Quantifiable assessment of motivational deficits and apathy in dementia – and beyond S Pollentier
slides 
slides
 video
  Treatment of apathy in psychiatry and neurodegenerative disorders: Are positive valence systems of reward shared in common? Early drug development implications L Ereshefsky
slides 
slides 
 video
  Concluding Discussant Discussant:
L Pani
slides 
slides
 video 
  Regulatory Viewpoints/Panel – Audience discussion – Apathy in AD Facilitators:
L Ereshefsky
S Pollentier
Panel:
T Farchione
V Mantua
slides
 slides 
Apathy speakers
 video
  Meeting Adjourns S Marder